A small Israeli company that hopes to revolutionise pre-natal testing through the use of artificial intelligence has had a successful debut on Australia's stock exchange.
Shares in Identifai Genetics were changing hands early Tuesday afternoon at 24 cents, up 20 per cent from their initial public offering price of 20 cents.